DarioHealth (DRIO) SEC Filings: History & Chart

DarioHealth Corp.(DRIO)

Medical - Specialties · New York City, NY

$6.06+0.26 (+4.48%)

Delayed quote: Oct 6, 2026, 11:00 AM EDT

About DarioHealth Corp.

DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.

New York City, NY

163 employees

www.dariohealth.com

Healthcare / Medical - Specialties

Sector: Healthcare
Industry: Medical - Specialties
CEO: Erez Raphael

View full financials

Form	Filing Date	Accepted	Document
4	Sep 28, 2026	Sep 28, 2026	View filing
4	Sep 28, 2026	Sep 28, 2026	View filing
4	Sep 28, 2026	Sep 28, 2026	View filing
4	Sep 28, 2026	Sep 28, 2026	View filing
4	Sep 28, 2026	Sep 28, 2026	View filing
4	Sep 28, 2026	Sep 28, 2026	View filing
4	Sep 28, 2026	Sep 28, 2026	View filing
4	Sep 28, 2026	Sep 28, 2026	View filing
3	Sep 28, 2026	Sep 28, 2026	View filing
8-K	Sep 4, 2026	Sep 4, 2026	View filing
8-K	Aug 21, 2026	Aug 21, 2026	View filing
10-Q	Aug 11, 2026	Aug 11, 2026	View filing
4	Jul 28, 2026	Jul 28, 2026	View filing
8-K	Jul 22, 2026	Jul 22, 2026	View filing
424B5	Jul 22, 2026	Jul 22, 2026	View filing
8-K	Jul 10, 2026	Jul 10, 2026	View filing
10-Q	May 13, 2026	May 13, 2026	View filing
SD	May 7, 2026	May 7, 2026	View filing
3	Apr 13, 2026	Apr 13, 2026	View filing
8-K	Apr 13, 2026	Apr 13, 2026	View filing
424B5	Mar 30, 2026	Mar 30, 2026	View filing
8-K	Mar 30, 2026	Mar 30, 2026	View filing
EFFECT	Mar 27, 2026	Mar 30, 2026	View filing
S-8	Mar 19, 2026	Mar 19, 2026	View filing
S-3	Mar 19, 2026	Mar 19, 2026	View filing
10-K	Mar 19, 2026	Mar 19, 2026	View filing
SC 13G/A	Feb 13, 2026	Feb 13, 2026	View filing
8-K	Feb 2, 2026	Feb 2, 2026	View filing
8-K	Jan 29, 2026	Jan 29, 2026	View filing
EFFECT	Jan 8, 2026	Jan 9, 2026	View filing

SEC Filings

Recent Filings